Tag: NATCO

Bengaluru-based Eyestem raises $6.4 mn in Series A funding round

by  • 

Cell therapy company Eyestem announced it has raised $6.4 million in a Series A funding round led by Biological E. Limited (BE), Alkem, NATCO and Anurag and Karan Bagaria, promoters of Kemwell Biopharma. Existing investors Endiya Partners and Kotak Private Equity also participated in the current funding round. Post this funding, Eyestem is valued at…

read more..

NATCO completes acquisition of Dash Pharmaceuticals LLC

by  • 

NATCO Pharma Inc. USA, a wholly owned subsidiary of NATCO Pharma Limited (NATCO), has completed the acquisition of Dash Pharmaceuticals LLC (Dash), a New Jersey based entity. Pursuant to this, Dash will become a 100% wholly owned subsidiary of NATCO Pharma Inc. and a step-down subsidiary of NATCO. The acquisition amount paid is US$ 18…

read more..